Advertisements



Roche"s Rituxan Gets Priority Review for Blood Disorder

Roche (RHHBY) gets Priority Review status from the FDA for Rituxan in children .....»»

Category: personnelSource: nytJun 12th, 2019

Genentech says Rituxan granted Priority Review by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2019

Benzinga"s Daily Biotech Pulse: Epidiolex, Roche"s Influenza Drug Gets Priority Review Status, Xeris Jumps On Positive Trial Results

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 25) read more.....»»

Category: blogSource: benzingaJun 26th, 2018

Roche"s (RHHBY) BLA for Lymphoma Drug Gets Priority Review

The FDA accepts Roche's (RHHBY) BLA for polatuzumab vedotin and NDAs for entrectinib, an.....»»

Category: dealsSource: nytFeb 19th, 2019

Roche"s (RHHBY) BLA for Lymphoma Drug Gets Priority Review

Zacks.....»»

Category: topSource: redinewsFeb 20th, 2019

Amarin Rises on Priority Review for Vascepa Label Expansion

Amarin's (AMRN) label expansion application for hypertriglyceridemia drug, Va.....»»

Category: smallbizSource: nytMay 30th, 2019

Amarin"s Cardiovascular Fish Oil Pill May Hit Market Sooner: FDA Accords Priority Review Designation

Shares of mid-cap biotech Amarin Corporation plc (NASDAQ: AMRN) are advancing solidly in pre-market trading Wednesday. read more.....»»

Category: blogSource: benzingaMay 29th, 2019

Amarin Priority Review could drive upside to estimates, says Cantor Fitzgerald

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2019

Amarin"s new drug application for vascepa granted Priority Review by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2019

J&J"s Janssen announces FDA priority review for Invokana

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2019

Bayer, Orion say FDA grants priority review for darolutamide

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 29th, 2019

Amarin"s Vascepa granted priority review status from Health Canada

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 29th, 2019

Biohaven priority review purchase could bring 2019 approval, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 18th, 2019

GW Pharma announces sale of priority review voucher for $105 million

GW Pharmaceuticals Plc said Monday it is selling its Rare Pediatric Disease Priority Review Vouch.....»»

Category: topSource: marketwatchMar 18th, 2019

GW Pharma announces sale of priority review voucher for $105 million

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 18th, 2019

Biotech Analysis Central Pharma News: Evoke"s Mishap, ImmunoGen"s Struggle, Eli Lilly"s Priority Review

Biotech Analysis Central Pharma News: Evoke"s Mishap, ImmunoGen"s Struggle, Eli Lilly"s Priority Review.....»»

Category: topSource: seekingalphaMar 8th, 2019

Regeneron, Sanofi announce FDA Priority Review of sBLA for Dupixent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 8th, 2019

Bristol-Myers" Opdivo Gets Priority Review for Lung Cancer

The FDA accepts Bristol-Myers Squibb's (BMY) supplemental Biologics License Application and grants priority review for the label expansion of Opdi.....»»

Category: smallbizSource: nytApr 19th, 2018

Bristol-Myers says FDA accepts sBLA for Opdivo for priority review

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 18th, 2018

Why Geron Corporation"s Stock Is Heading Higher Today

Geron's experimental blood cancer drug remains a top priority for the pharma behemoth Johnson & Johnson......»»

Category: topSource: foxnewsApr 17th, 2018

Commission OKs 20 recreational marijuana applicants for review

Over 600 users have registered for priority applications to operate recreational marijuana dispensaries through the Cannabis Control Commission as of 8 p.m. Monday evening. Twenty of those saw their registered marijuana dispensary applications app.....»»

Category: topSource: bizjournalsApr 10th, 2018